Personal Capital Advisors Corp - IMMUNE DESIGN CORP ownership

IMMUNE DESIGN CORP's ticker is IMDZ and the CUSIP is 45252L103. A total of 81 filers reported holding IMMUNE DESIGN CORP in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Personal Capital Advisors Corp ownership history of IMMUNE DESIGN CORP
ValueSharesWeighting
Q4 2018$49,000
-41.0%
37,500
+56.2%
0.00%0.0%
Q3 2018$83,000
-23.9%
24,0000.0%0.00%
-50.0%
Q2 2018$109,000
+38.0%
24,0000.0%0.00%
+100.0%
Q1 2018$79,000
-16.0%
24,0000.0%0.00%
-50.0%
Q4 2017$94,000
-72.5%
24,000
-27.4%
0.00%
-71.4%
Q3 2017$342,000
-3.9%
33,056
-9.4%
0.01%
-12.5%
Q2 2017$356,00036,5000.01%
Other shareholders
IMMUNE DESIGN CORP shareholders Q2 2018
NameSharesValueWeighting ↓
COLUMN GROUP L P 3,161,942$65,294,000100.00%
ProQuest Associates IV LLC 1,983,858$40,967,0008.41%
Iguana Healthcare Management, LLC 150,000$3,098,0000.98%
SECTORAL ASSET MANAGEMENT INC 810,390$16,735,0000.70%
Cormorant Asset Management, LP 189,000$3,903,0000.52%
SPHERA FUNDS MANAGEMENT LTD. 140,000$2,891,0000.28%
RS INVESTMENT MANAGEMENT CO LLC 750,402$15,496,0000.13%
Eventide Asset Management 102,904$2,125,0000.12%
Rock Springs Capital Management LP 55,000$1,136,0000.08%
Focused Wealth Management, Inc 3,406$70,0000.04%
View complete list of IMMUNE DESIGN CORP shareholders